Comparing earlier and later treatment of gestational diabetes in pregnancy
Compares starting care early or later in pregnant women with gestational diabetes.
Key facts
- Who runs it
- University Hospital, Lille
- Where
- France10 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Early Gestational Diabetes Mellitus
- Status
- Recruiting
- People taking part
- 2,010 people, planned
- Started
- 30 Nov 2020
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- late management strategy
- early management strategy
- Record updated
- 2 June 2026
Who can take part
The trial is looking for pregnant women with early gestational diabetes (high blood sugar found early in pregnancy). It compares starting diabetes care early with starting it later.
- Age
- 18 Years and older
- Sex
- Female only
- Disease stage
- Early gestational diabetes: fasting blood sugar between 5.1 mmol/l (92 mg/dL) and 6.1 mmol/l (110 mg/dL). At least one risk factor is needed: age ≥35 years, BMI ≥ 25 kg/m2, diabetes in the family, gestational diabetes in a past pregnancy, or a past very large baby. Pregnancy with one baby only. First pregnancy visit before 20 weeks of pregnancy.
- Earlier treatment
- Diabetes follow-up must not have started already at the time of joining. People on long-term corticosteroid treatment cannot join.
- Biomarker or test result
- Fasting plasma glucose between 5.1 mmol/l (92 mg/dL) and 6.1 mmol/l (110 mg/dL).
- Main reasons for not taking part
- Diabetes that existed before the pregnancy
- Kidney or liver problems
- Past weight-loss (bariatric) surgery
- Long-term corticosteroid treatment
- Not enough understanding, language difficulties or no social insurance
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant woman
Show the full registry criteria (17)Hide the full registry criteria
Who can take part
- Pregnant woman
- Singleton pregnancy
- Early GDM defined by a fasting plasma glucose between 5.1 mmol/l and 6.1 mmol/ with at least one risk factor (age ≥35 years and/or BMI ≥ 25 kg/m2 and/or familial history of diabetes and/or personal history of GDM and/or personal history of macrosomia)
- First prenatal visit prior 20 weeks of gestation at the time of randomization
- Signed informed consent
Who cannot take part
- Long time corticosteroids treatment
- Pre-existing diabetes in pregnancy
- Renal impairment
- Hepatic insufficiency
- History of bariatric surgery
- Diabetic follow-up started at time of inclusion
- Insufficient understanding
- Language difficulties
- Lack of social Insurance
- Person in emergency situation
- Person under the protection of justice (tutelage/ curatorship)
- Persons deprived of their liberty
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Gestational diabetes
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) panel published consensus-based recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Cognizant that milder degrees of hyperglycemia would also be detected by early pregnancy testing, the IADPSG recommended that fasting plasma glucose (FPG) in the range of 5.1-6.9 mmol/l should be considered diagnostic of early Gestational Diabetes Mellitus (GDM) even if the level of proof for this recommendation is very low regarding to prognosis. This threshold was extrapolated from the FPG value used between 24 and 28 weeks.
Read full original descriptionShow less
In France, a FPG is proposed at the first prenatal visit for women with risk factors of GDM. Early GDM is diagnosed if FPG is ≥ 5.1 mmol/l, leading to an intensive metabolic management. Data have shown that GDM prevalence increased rapidly from 5.9% in 2009 to 9.3% in 2014. 26.9% of women with hyperglycemia during their pregnancy but without known diabetes are treated before 22 weeks' gestation (WG). More recent data from Italy and China, where IADPSG diagnosis criteria were applied, have strongly challenged this recommendation, and showed that early FPG ≥ 5.1mmo/L is poorly predictive of later GDM. No prior studies have demonstrated benefits to early screening and management. In 2016, the IADPSG members have suggested that the use of the FPG threshold ≥5.1 mmol/l for the identification of GDM in early pregnancy is not justified by current evidence
The 2 groups in the trial
- Early management GDM groupTreatment being tested
defined as no intervention until GDM screening at 24-28 weeks' gestation. If there is a diagnosis of GDM at 24-28 according to the IADPSG criteria), intensive metabolic treatment until delivery
Treatment: early management strategy
- Late management GDM groupTreatment being tested
early management of GDM defined as intensive metabolic treatment (diet, physical activity self-blood glucose monitoring according and/or insulin therapy according to the French guidelines). This intensive treatment will begin after the randomization until delivery.
Treatment: late management strategy
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Late Versus Early Management of Gestational Diabetes Mellitus: a Non Inferiority Randomized Multicenter Trial
- Plain-language title
- Comparing earlier and later treatment of gestational diabetes in pregnancyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT04451915, who can take part
- Record updated
- 2 June 2026